Literature DB >> 11231444

Usefulness of cardiac troponin I in patients undergoing open heart surgery.

N Greenson1, J Macoviak, P Krishnaswamy, R Morrisey, C James, P Clopton, R Fitzgerald, A S Maisel.   

Abstract

BACKGROUND: Significant myocardial injury during cardiac surgery is associated with a 10-fold increase in 2-year complication rates, yet there remains no clinical gold standard for diagnosis. Troponin I has complete cardiospecificity and is clinically used for diagnosis of myocardial infarction in other settings. METHODS AND
RESULTS: One hundred consecutive patients undergoing open heart surgery (71 coronary artery bypass grafts and 29 aortic valve replacements) were enrolled and blood samples were drawn preoperatively, at 5 AM and 5 PM on days 1 and 2 after surgery, and at 5 AM for 3 more days. Twelve-lead electrocardiograms were performed daily and echocardiographic studies were performed on patients with either; electrocardiographic changes signifying likely myocardial damage, intraoperative complications, or elevated creatine kinase subfraction MB or troponin values. Seventeen patients had either new wall motion abnormalities or new Q waves all with peak cardiac troponin I >40 ng/mL. Stratification of patients by peak troponin values <40 and >60 ng/mL was highly predictive (P <.001) of days in intensive care unit, days on ventilator, development of new arrhythmia, and especially cardiac events. These postoperative variables also showed a stronger correlation with peak cardiac troponin I than did peak creatine kinase subfraction MB.
CONCLUSION: Peak troponin I values detect myocardial infarction the day after heart surgery and predicts patient outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231444     DOI: 10.1067/mhj.2001.113071

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  A review of troponins in ischemic heart disease and other conditions.

Authors:  Nedaa Skeik; Deevia Chandrakant Patel
Journal:  Int J Angiol       Date:  2007

Review 2.  Redefining myocardial infarction for the 21st century.

Authors:  Joseph S Alpert; Beth R Malasky; Kristian Thygesen
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

Review 3.  Troponin: the biomarker of choice for the detection of cardiac injury.

Authors:  Luciano Babuin; Allan S Jaffe
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

4.  Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery.

Authors:  Jochen D Muehlschlegel; Kuang-Yu Liu; Tjörvi E Perry; Amanda A Fox; Charles D Collard; Stanton K Shernan; Simon C Body
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

5.  MASP-2 activation is involved in ischemia-related necrotic myocardial injury in humans.

Authors:  Ming Zhang; Yunfang Joan Hou; Erdal Cavusoglu; Daniel C Lee; Rudi Steffensen; Liming Yang; Daniel Bashari; Jose Villamil; Motaz Moussa; George Fernaine; Jens C Jensenius; Jonathan D Marmur; Wilson Ko; Ketan Shevde
Journal:  Int J Cardiol       Date:  2011-12-15       Impact factor: 4.164

6.  Perioperative myocardial infarction diagnosis after coronary artery bypass grafting surgery using coupled electrocardiographic changes and cardiac troponin I.

Authors:  Arvin Shahzamani; Erfan Sheikhbahaei; Shahab Shahabi; Mehran Shahzamani; Helia Hemasian; Niayesh Hadi; Sara Zamani
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-08-28

7.  Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Luigino Nascimben; Amanda A Fox; Charles D Collard; Edwin G Avery; Sary F Aranki; Michael N D'Ambra; Stanton K Shernan; Simon C Body
Journal:  Eur Heart J       Date:  2009-04-30       Impact factor: 29.983

8.  Clinical and Functional Outcomes Associated With Myocardial Injury After Transfemoral and Transapical Transcatheter Aortic Valve Replacement: A Subanalysis From the PARTNER Trial (Placement of Aortic Transcatheter Valves).

Authors:  Jean-Michel Paradis; Hersh S Maniar; John M Lasala; Susheel Kodali; Mathew Williams; Brian R Lindman; Ralph J Damiano; Marc R Moon; Raj R Makkar; Vinod H Thourani; Vasilis Babaliaros; Ke Xu; Girma Minalu Ayele; Lars Svensson; Martin B Leon; Alan Zajarias
Journal:  JACC Cardiovasc Interv       Date:  2015-09       Impact factor: 11.195

Review 9.  Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers.

Authors:  Joseph A Sparano; David L Brown; Antonio C Wolff
Journal:  Drug Saf       Date:  2002       Impact factor: 5.228

10.  [Kinetics of cTnI and threshold values for the diagnosis of myocardial infarction after cardiac surgery with cardiopulmonary bypass].

Authors:  Samy Kallel; Anwar Jarraya; Maged Ellouze; Imed Frikha; Abbdelhamid Karoui
Journal:  Pan Afr Med J       Date:  2012-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.